This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
D

ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab in Platinum-Sensitive Relapsed Mesothelioma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Dean Fennell
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Dean Fennell
96 views
June 6, 2024

Chapters

MIST5 Trial Results & Conclusions

00:00

Study Design & Patient Characteristics

01:16

Efficacy, Safety & Correlative Research

04:35

0 Comments
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

2024 ASCO® Annual Meeting Insights Hub: Lung Videos

17:22
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths…

Feat. A. Chiang
40:00
ecancer

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

Feat. B. Gyawali
04:26
ecancer

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local C…

Feat. P. Iyengar
View All

Related Content

AUTOPLAY
36:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
12:10
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - A…

Feat. M. Marmarelis
04:35
Total Health

Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…

Feat. J. Bauman
15:37
ImmunoTherapy Bridge 2023

What’s New in NSCLC & Mesothelioma Immunotherapy

Feat. A. Morabito
11:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab …

Feat. S. Popat
10:31
MI&T Congressi

Immunotherapy for Patients With Mesothelioma

Feat. J. Aerts
08:14
2023 Texas Lung Cancer Conference Coverage

Updates in Malignant Pleural Mesothelioma

Feat. M. Marmarelis
22:02
OncoAlert

Significant Advances in Mesothelioma

Feat. G. Mountzios
09:04
Oncology Data Advisor

Discovering Research Advances in Mesothelioma

Feat. S. Kareff, E. Rodriguez
07:11
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "First Survival Data From the NIPU Trial - …

Feat. A. Helland
09:57
ILCC 2022 Conference Coverage

ILCC 2022 Mesothelioma: Updates in Systemic Therapy

Feat. P. Baas
08:40
Laura Ridolfi

MESOVAX Clinical Trial of Pembro & Dendritic Cell Vaccine in Adv…

05:39
GRACE

ASCO® 2023 Insights: "Chemo +/- IO for Mesothelioma"

Feat. J. West, C. Lovly, A. Addeo
05:22
ecancer

ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …

Feat. S. Peters
15:09
Oncology Data Advisor

World Lung Cancer Day: Key Insights and Advances in Lung Cancer Trea…

Feat. S. Kareff, B. Sandy, M. Vojnic
04:33
ecancer

ASCO® 2023 Insights: "Pembro in 1L Treatment for Unresectable A…

Feat. P. Bradbury
09:56
2020 Virtual ESMO Review

2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost…

Feat. M. Dietrich
16:56
WCLC 2022 Conference Coverage

WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Ma…

Feat. M. Jakopovic
17:52
Memorial Sloan Kettering Cancer Center

Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on A…

Feat. M. Zauderer